Table 2.
Panellist demographics
| Panellist demographics | Number of panellists, n (%) |
|---|---|
| Professional roles of panellists | |
| Neurologist | 6 (60.0) |
| Metabolic specialist | 1 (10.0) |
| Geneticist | 1 (10.0) |
| Paediatric metabolic specialist | 1 (10.0) |
| Other* | 1 (10.0) |
| Place of work of panellists | |
| Specialist centre/department | 7 (70.0) |
| Local hospital | 2 (20.0) |
| Other† | 1 (10.0) |
| Country panellists practice in | |
| Italy | 3 (30.0) |
| Israel | 2 (20.0) |
| Turkey | 2 (20.0) |
| France | 1 (10.0) |
| The Netherlands | 1 (10.0) |
| USA | 1 (10.0) |
| Number of patients treated in the past 10 years | |
| ≥ 21 patients | 4 (40.0) |
| 16–20 patients | 1 (10.0) |
| 11–15 patients | 2 (20.0) |
| 6–10 patients | 1 (10.0) |
| ≤ 5 patients | 2 (20.0) |
| Panellists’ experience in treating adult and paediatric patients | |
| Adult patients only | 4 (40.0) |
| Adult and paediatric patients | 6 (60.0) |
| Years of experience in treating patients with CTX | |
| ≥ 21 years | 3 (30.0) |
| 16–20 years | 2 (20.0) |
| 11–15 years | 0 (0.0) |
| 6–10 years | 3 (30.0) |
| ≤ 5 years | 2 (20.0) |
Demographics of panellists that responded to the Round 1 questionnaire
*‘Other’ response selected and free-text specified as ‘pediatrician, clinical geneticist, and clinical biochemical geneticist (metabolic specialist)’
†‘Other’ response selected and free-text specified as ‘university hospital’
CTX: Cerebrotendinous xanthomatosis